Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children
Rubhana Raqib, Protim Sarker, Khalequ Zaman, et al.
Human Vaccines & Immunotherapeutics (2019) Vol. 15, Iss. 6, pp. 1326-1337
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The Shigella Vaccines Pipeline
Calman A. MacLennan, Stephanie Grow, Lyou‐Fu Ma, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1376-1376
Open Access | Times Cited: 73
<p><em>Shigella</em>: Antibiotic-Resistance Mechanisms And New Horizons For Treatment</p>
Reza Ranjbar, Abbas Farahani
Infection and Drug Resistance (2019) Vol. Volume 12, pp. 3137-3167
Open Access | Times Cited: 141
Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate
Girmay Desalegn, Chitradevi S. Tamilselvi, Jose M. Lemme‐Dumit, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Advanced oral vaccine delivery strategies for improving the immunity
Yuandong Zhang, Man Li, Guangsheng Du, et al.
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113928-113928
Closed Access | Times Cited: 48
The Ongoing Journey of a Shigella Bioconjugate Vaccine
Patricia Martín, Cristina Alaimo
Vaccines (2022) Vol. 10, Iss. 2, pp. 212-212
Open Access | Times Cited: 29
Toward a Shigella Vaccine: Opportunities and Challenges to Fight an Antimicrobial-Resistant Pathogen
Maria Michelina Raso, Vanessa Arato, Gianmarco Gasperini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4649-4649
Open Access | Times Cited: 22
Shigella Vaccines: The Continuing Unmet Challenge
Ti Lu, Sayan Das, Debaki R. Howlader, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4329-4329
Open Access | Times Cited: 7
Vaccines against gastroenteritis, current progress and challenges
Hyesuk Seo, Qiangde Duan, Weiping Zhang
Gut Microbes (2020) Vol. 11, Iss. 6, pp. 1486-1517
Open Access | Times Cited: 37
Combatting infectious diarrhea: innovations in treatment and vaccination strategies
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 246-265
Open Access | Times Cited: 4
BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice
Matthew E. Sherman, Jane Michalski, Sayan Das, et al.
Vaccine (2025) Vol. 50, pp. 126779-126779
Open Access
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine
Valentino Conti, Omar Rossi, Kristen A. Clarkson, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants
Ann‐Mari Svennerholm, Firdausi Qadri, Anna Lundgren, et al.
Vaccine (2021) Vol. 40, Iss. 2, pp. 380-389
Open Access | Times Cited: 20
Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry
Meagan Kelly, Anjali Mandlik, Richelle C. Charles, et al.
Vaccine (2023) Vol. 41, Iss. 34, pp. 4967-4977
Open Access | Times Cited: 7
Detoxified O-Specific Polysaccharide (O-SP)–Protein Conjugates: Emerging Approach in the Shigella Vaccine Development Scene
Dani Cohen, Shiri Meron-Sudai, Anya Bialik, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 675-675
Open Access | Times Cited: 11
Plant‐Made Vaccines Targeting Enteric Pathogens—Safe Alternatives for Vaccination in Developing Countries
Edgar Trujillo, Carlos Angulo
Biotechnology and Bioengineering (2024)
Closed Access | Times Cited: 2
Vaccines for enteric diseases
Dani Cohen, Khitam Muhsen
Human Vaccines & Immunotherapeutics (2019) Vol. 15, Iss. 6, pp. 1205-1214
Open Access | Times Cited: 17
Functional Antibodies and Innate Immune Responses to WRSS1, a Live Oral Shigella sonnei Vaccine Candidate, in Bangladeshi Adults and Children
Protim Sarker, Akhirunnesa Mily, Anjuman Ara, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. Supplement_7, pp. S829-S839
Open Access | Times Cited: 14
Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target
Alan S. Cross
Microbiology and Molecular Biology Reviews (2023) Vol. 87, Iss. 3
Open Access | Times Cited: 5
A guide to oral vaccination: Highlighting electrospraying as a promising manufacturing technique toward a successful oral vaccine development
Ahmad M. Aldossary, Chinedu Ekweremadu, Ifunanya M. Offe, et al.
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 6, pp. 655-668
Open Access | Times Cited: 8
Antimicrobial, anti-adhesive, and anti-invasive effects of condition media derived from adipose mesenchymal stem cells against Shigella flexneri
H Mahmoudjanlou, Masoumeh Saberpour, Bita Bakhshi
Archives of Microbiology (2024) Vol. 206, Iss. 4
Closed Access | Times Cited: 1
Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge
Meagan Kelly, Jeshina Janardhanan, Chanchal Wagh, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126263-126263
Open Access | Times Cited: 1
Antibiotic resistance and serotype distribution of Shigella strains in Bangladesh over the period of 2014–2022: evidence from a nationwide hospital-based surveillance for cholera and other diarrheal diseases
Mokibul Hassan Afrad, Md Taufiqul Islam, Yasmin Ara Begum, et al.
Microbiology Spectrum (2024)
Open Access | Times Cited: 1
Occurrence of shigellosis in pediatric diarrheal patients in Chattogram, Bangladesh: A molecular based approach
A. K. M. Zakir Hossain, Md. Zahid Hasan, Sohana Akter Mina, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0275353-e0275353
Open Access | Times Cited: 3
Recent Progress in Shigella and Burkholderia pseudomallei Vaccines
Itziar Chapartegui-González, Sarah Bowser, Alfredo G. Torres, et al.
Pathogens (2021) Vol. 10, Iss. 11, pp. 1353-1353
Open Access | Times Cited: 4
BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice
Robert K. Ernst, Matthew E. Sherman, Jane Michalski, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top